Shenzhen - Delayed Quote CNY
Baolingbao Biology Co.,Ltd. (002286.SZ)
9.90
-0.37
(-3.60%)
As of 2:22:48 PM GMT+8. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,535,329.92
2,401,754.84
2,523,914.01
2,712,745.32
2,764,976.97
Cost of Revenue
2,211,453
2,116,363.78
2,319,381.87
2,399,932.38
2,394,788.94
Gross Profit
323,876.92
285,391.06
204,532.14
312,812.93
370,188.03
Operating Expense
129,297.36
123,802.84
112,458.44
145,194.23
137,965.87
Operating Income
194,579.56
161,588.22
92,073.69
167,618.70
232,222.16
Net Non Operating Interest Income Expense
-8,462.95
-8,914.79
-18,784.65
-23,395.27
-12,880.73
Pretax Income
163,017.33
131,113.67
65,114.55
156,689.74
236,737.46
Tax Provision
24,670.01
19,953.85
11,145.53
23,520.90
35,158.06
Net Income Common Stockholders
138,347.32
111,159.81
53,969.02
133,168.84
201,579.40
Basic EPS
0.38
--
0.15
0.36
0.54
Diluted EPS
0.38
--
0.15
0.36
0.54
Basic Average Shares
363,919.56
--
359,793.47
369,913.44
373,295.19
Diluted Average Shares
363,919.56
--
359,793.47
369,913.44
373,295.19
Total Operating Income as Reported
183,891.24
153,966.96
64,007.67
160,229.54
235,930.34
Rent Expense Supplemental
--
775.34
808.35
1,028.45
2,273.29
Total Expenses
2,340,750.36
2,240,166.62
2,431,840.31
2,545,126.62
2,532,754.81
Net Income from Continuing & Discontinued Operation
138,347.32
111,159.81
53,969.02
133,168.84
201,579.40
Normalized Income
147,428.41
117,305.37
64,577.14
132,725.36
195,765.92
Interest Income
4,081.80
4,997.65
5,454.19
4,658.64
4,814.57
Interest Expense
12,591.87
13,039.10
22,677.96
26,538.88
16,949.40
Net Interest Income
-8,462.95
-8,914.79
-18,784.65
-23,395.27
-12,880.73
EBIT
175,609.20
144,152.77
87,792.51
183,228.62
253,686.86
EBITDA
175,609.20
263,697.55
210,532.57
288,853.85
358,667.43
Reconciled Cost of Revenue
2,211,453
2,116,363.78
2,319,381.87
2,399,932.38
2,394,788.94
Reconciled Depreciation
--
119,544.78
122,740.06
105,625.23
104,980.57
Net Income from Continuing Operation Net Minority Interest
138,347.32
111,159.81
53,969.02
133,168.84
201,579.40
Total Unusual Items Excluding Goodwill
-10,700.43
-7,248.72
-12,798.88
521.81
6,827.43
Total Unusual Items
-10,700.43
-7,248.72
-12,798.88
521.81
6,827.43
Normalized EBITDA
186,309.63
270,946.27
223,331.45
288,332.04
351,840
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,619.34
-1,103.16
-2,190.76
78.33
1,013.95
12/31/2021 - 8/28/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade